Evidence map›Paper›PMID 42515085›Full record

ArticlePathogens (Basel, Switzerland)2026

Fosfomycin Resistance Dynamics in Major Uropathogens: A 2013-2025 Integrated Disease Surveillance of Multidrug-Resistant, Extended-Spectrum Beta-Lactamase-Producing, Non-Extended-Spectrum Beta-Lactamase, and Enterococcal Urinary Isolates.

Umar Saeed, Rizwan Uppal, Gohar Zaman, Muhammad Rehan Uppal, Zsolt Jenő Szepesváry, Aftab Ahmad Khan, Muhammad Usman Qamar, Zuhaib Ali, Zahra Zahid Piracha

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Umar SaeedClinical and Biomedical Research Center (CBRC), Foundation University School of Health Sciences (FUSH), Foundation University Islamabad (FUI), Islamabad 44000, Pakistan.
Rizwan UppalInternational Center of Medical Sciences Research (ICMSR), Islamabad 44000, Pakistan.
Gohar ZamanIslamabad Diagnostic Center (IDC), Islamabad 44000, Pakistan.
Muhammad Rehan UppalInternational Center of Medical Sciences Research (ICMSR), Islamabad 44000, Pakistan.
Zsolt Jenő SzepesváryFaculty of Health, Széchenyi István University, 9026 Győr, Hungary.ORCID 0000-0002-5628-4300
Aftab Ahmad KhanIslamabad Diagnostic Center (IDC), Islamabad 44000, Pakistan.
Muhammad Usman QamarInstitute of Microbiology, Faculty of Life Sciences, Government College University Faisalabad, Faisalabad 38000, Pakistan.ORCID 0000-0002-2636-238X
Zuhaib AliIslamabad Diagnostic Center (IDC), Islamabad 44000, Pakistan.
Zahra Zahid PirachaInternational Center of Medical Sciences Research (ICMSR), Islamabad 44000, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urinary tract infections are among the most common bacterial infections encountered in clinical practice, with

Indexed as

Anti-Bacterial Agentsbeta-LactamasesDrug Resistance, Multiple, BacterialEnterococcusFosfomycinUrinary Tract InfectionsEscherichia coliHumansMicrobial Sensitivity TestsPakistanRetrospective StudiesAnti-Bacterial Agentsbeta-LactamasesFosfomycinantimicrobial stewardshipEnterococcus spp.Escherichia colifosfomycin resistanceKlebsiella spp.Pakistanurinary tract infections

Identifiers

PMID42515085
PMCPMC13414490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.